Project Number 5R01MH060883-08 Agency/Funding Organization NIMH Funding Year 2008 View Full Project Details for CORTICOLIMBIC DEGENERATION AND TREATMENT OF DEMENTIA Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 7. Circuits and Synapses c. Neurotransmitter Receptors Structure and Function Researcher and Organization Principal Investigator CSERNANSKY, JOHN G Principal Investigator First Name JOHN G Principal Investigator Last Name CSERNANSKY Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail FY Overall Cost $152,506 Funding Organization Agency/Funding Organization NIMH Funding Organization Country United States Program Official EVANS, JOVIER D Related Resources Repository [AlzPED] Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease [AlzPED] Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's Disease [AlzPED] Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease Clinical Trial Corticolimbic Degeneration and Treatment of Dementia
